L. Gallinaro

发表

An apparently silent nucleotide substitution (c.7056C>T) in the von Willebrand factor gene is responsible for type 1 von Willebrand disease

A. Bertomoro, V. Daidone, A. Casonato, 2011, Haematologica.

Type 1 von Willebrand disease due to reduced von Willebrand factor synthesis and/or survival: observations from a case series.

A. Bertomoro, R. Padrini, V. Daidone, 2010, Translational research : the journal of laboratory and clinical medicine.

Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia

Alessandra Casonato, A. Bertomoro, R. Padrini, 2010, Haematologica.

A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor.

A. Bertomoro, R. Padrini, V. Daidone, 2008, Blood.

A novel von Willebrand factor mutation (I1372S) associated with type 2B-like von Willebrand disease: An elusive phenotype and a difficult diagnosis

A. Bertomoro, V. Daidone, A. Casonato, 2007, Thrombosis and Haemostasis.

Combined partial exon skipping and cryptic splice site activation as a new molecular mechanism for recessive type 1 von Willebrand disease

A. Bertomoro, L. Bartoloni, A. Casonato, 2006, Thrombosis and Haemostasis.

Diagnosis and Follow-up of Thrombotic Thrombocytopenic Purpura by Means of von Willebrand Factor Collagen Binding Assay

F. Fabris, A. Girolami, A. Casonato, 2006, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Identifying type Vicenza von Willebrand disease.

A. Rosato, A. Bertomoro, R. Padrini, 2006, The Journal of laboratory and clinical medicine.

Origins of mitochondrial thymidine triphosphate: Dynamic relations to cytosolic pools

P. Reichard, V. Bianchi, L. Gallinaro, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Von Willebrand factor propeptide makes it easy to identify the shorter Von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease

R. Padrini, V. Daidone, A. Casonato, 2008, British journal of haematology.

A common ancestor more than 10,000 years old for patients with R854Q-related type 2N von Willebrand's disease in Italy

L. Marullo, G. Bertorelle, V. Daidone, 2013, Haematologica.

Identifying Carriers of Type 2N von Willebrand Disease

A. Bertomoro, P. Perutelli, A. Casonato, 2007, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Mammalian 5′(3′)-Deoxyribonucleotidase, cDNA Cloning, and Overexpression of the Enzyme in Escherichia coli and Mammalian Cells*

U. Hellman, A. Karlsson, P. Reichard, 2000, The Journal of Biological Chemistry.

Human Mitochondrial 5′-Deoxyribonucleotidase

P. Reichard, V. Bianchi, C. Rampazzo, 2002, The Journal of Biological Chemistry.

A deoxyribonucleotidase in mitochondria: involvement in regulation of dNTP pools and possible link to genetic disease.

E. Frigimelica, P. Reichard, V. Bianchi, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Induction of human high K(M) 5'-nucleotidase in cultured 293 cells.

P. Reichard, V. Bianchi, C. Rampazzo, 1999, Experimental cell research.

Human high-Km 5'-nucleotidase effects of overexpression of the cloned cDNA in cultured human cells.

P. Reichard, V. Bianchi, M. Johansson, 1999, European journal of biochemistry.

Effects of overexpression of the cloned cDNA in cultured human cells

P. Reichard, V. Bianchi, M. Johansson, 1999 .

Cytosolic and mitochondrial deoxyribonucleotidases: activity with substrate analogs, inhibitors and implications for therapy.

J. Balzarini, A. Karlsson, C. Mazzon, 2003, Biochemical pharmacology.

Altered von Willebrand factor subunit proteolysis and multimer processing associated with the Cys2362Phe mutation in the B2 domain

Z. Ruggeri, A. Casonato, M. Battiston, 2006, Thrombosis and Haemostasis.

Microsatellite (GT)n repeats and SNPs in the von Willebrand factor gene promoter do not influence circulating von Willebrand factor levels under normal conditions

C. Scaroni, V. Daidone, A. Casonato, 2009, Thrombosis and Haemostasis.

Uneventful coronary artery bypass surgery without prophylactic replacement therapy in a patient with a novel heterozygous FVII gene deletion

F. Vianello, G. Cella, L. Gallinaro, 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

Von Willebrand factor propeptide makes it easy to identify the shorter Von Willebrand factor survival in patients with type 1

R. Padrini, V. Daidone, A. Casonato, 2008 .

A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor.

A. Bertomoro, R. Padrini, V. Daidone, 2008, Blood.

Multiple von Willebrand factor mutations in patients with recessive type 1 von Willebrand disease.

V. Daidone, A. Casonato, E. Pontara, 2007, Thrombosis research.